Hospital Universitario Son Espases-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2025

  1. SEOM-GEIS Spanish clinical guidelines for the management of soft‑tissue sarcomas (2024)

    Clinical and Translational Oncology, Vol. 27, Núm. 4, pp. 1460-1471

2024

  1. Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

    The Lancet, Vol. 403, Núm. 10421, pp. 31-43

  2. Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol

    Pharmaceutics, Vol. 16, Núm. 12

2023

  1. Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2A

    Signal Transduction and Targeted Therapy, Vol. 8, Núm. 1

2021

  1. A growth modulation index-based geistra score as a new prognostic tool for trabectedin efficacy in patients with advanced soft tissue sarcomas: A Spanish group for sarcoma research (GEIS) retrospective study

    Cancers, Vol. 13, Núm. 4, pp. 1-15

2017

  1. Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumors

    Clinical and Translational Oncology, Vol. 19, Núm. 3, pp. 386-395

2016

  1. A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia

    British Journal of Cancer, Vol. 114, Núm. 11, pp. 1191-1198